LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients

CONCLUSION: PD1 and LAG3 in CD8+ T cells may be important targets of therapy and play therapeutic role in patients with DLBCL.PMID:34422089 | PMC:PMC8378962 | DOI:10.1155/2021/4468140

Source: Computational and Mathematical Methods in Medicine - August 23, 2021 Category: Statistics Authors: Ying Liu Xinhong Guo Lingbo Zhan Lei Wang Xinyou Wang Ming Jiang Source Type: research